<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR28">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>Q</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib</article-title>
  <source>Cancer Chemother Pharmacol</source>
  <year>2013</year>
  <volume>72</volume>
  <issue>5</issue>
  <fpage>1043</fpage>
  <lpage>1053</lpage>
  <pub-id pub-id-type="doi">10.1007/s00280-013-2282-y</pub-id>
  <pub-id pub-id-type="pmid">24043137</pub-id>
 </element-citation>
</ref>
